Literature DB >> 16889980

Preparation of hepatitis C virus structural and non-structural protein fragments and studies of their immunogenicity.

Marija Mihailova1, Melanie Fiedler, Mechthild Boos, Ivars Petrovskis, Irina Sominskaya, Michael Roggendorf, Sergei Viazov, Paul Pumpens.   

Abstract

Plasmids pQE-60 and pQE-30 containing 6 x His-tag sequence were used for expression of fragments of HCV structural and non-structural proteins in Escherichia coli (E. coli). The following fragments were used: core (1-98 aa), NS3 (202-482 aa), and tetramer of hypervariable region 1 (HVR1) of E2 protein. The constructed plasmids directed high levels of expression of HCV proteins in E. coli JM109. After purification by the metal-affinity chromatography on nickel-nitrilotriacetic acid (Ni-NTA) agarose, the His-tagged HCV proteins were used for immunization of BALB/c mice. All three proteins were able to induce high levels of specific antibodies and, in the case of the NS3 and HVR1 tetramer, also to mount vigorous cell-proliferating responses. High immunogenicity of the tested fragments of HCV proteins shows them as good candidates for inclusion into the future HCV vaccine preparations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16889980     DOI: 10.1016/j.pep.2006.06.011

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  7 in total

1.  Expression and Purification of HCV Core and Core-E1E2 Proteins in Different Bacterial Strains.

Authors:  Seyyedeh Masumeh Mirnurollahi; Azam Bolhassani; Shiva Irani; Noushin Davoudi
Journal:  Iran J Biotechnol       Date:  2015-09       Impact factor: 1.671

2.  Construction and immunological evaluation of multivalent hepatitis B virus (HBV) core virus-like particles carrying HBV and HCV epitopes.

Authors:  Irina Sominskaya; Dace Skrastina; Andris Dislers; Denis Vasiljev; Marija Mihailova; Velta Ose; Dzidra Dreilina; Paul Pumpens
Journal:  Clin Vaccine Immunol       Date:  2010-04-21

3.  Evaluation of the immunogenicity of liposome encapsulated HVR1 and NS3 regions of genotype 3 HCV, either singly or in combination.

Authors:  Gouri M Gupte; Vidya A Arankalle
Journal:  Virol J       Date:  2012-03-27       Impact factor: 4.099

4.  The Immunogenicity in Mice of HCV Core Delivered as DNA Is Modulated by Its Capacity to Induce Oxidative Stress and Oxidative Stress Response.

Authors:  Juris Jansons; Irina Sominskaya; Natalia Petrakova; Elizaveta S Starodubova; Olga A Smirnova; Ekaterina Alekseeva; Ruta Bruvere; Olesja Eliseeva; Dace Skrastina; Elena Kashuba; Marija Mihailova; Sergey N Kochetkov; Alexander V Ivanov; Maria G Isaguliants
Journal:  Cells       Date:  2019-02-28       Impact factor: 6.600

5.  Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen.

Authors:  Ekaterina Alekseeva; Irina Sominskaya; Dace Skrastina; Irina Egorova; Elizaveta Starodubova; Eriks Kushners; Marija Mihailova; Natalia Petrakova; Ruta Bruvere; Tatyana Kozlovskaya; Maria Isaguliants; Paul Pumpens
Journal:  Genet Vaccines Ther       Date:  2009-06-08

6.  Comparative Immunogenicity in Rabbits of the Polypeptides Encoded by the 5' Terminus of Hepatitis C Virus RNA.

Authors:  Irina Sominskaya; Juris Jansons; Anastasija Dovbenko; Natalia Petrakova; Ilva Lieknina; Marija Mihailova; Oleg Latyshev; Olesja Eliseeva; Irina Stahovska; Inara Akopjana; Ivars Petrovskis; Maria Isaguliants
Journal:  J Immunol Res       Date:  2015-11-02       Impact factor: 4.818

7.  Recombinant Nonstructural 3 Protein, rNS3, of Hepatitis C Virus Along With Recombinant GP96 Induce IL-12, TNFα and α5integrin Expression in Antigen Presenting Cells.

Authors:  Mohammad Reza Hajizadeh; Pooneh Mokarram; Eskandar Kamali Sarvestani; Azam Bolhassani; Zohreh Mostafavi Pour
Journal:  Hepat Mon       Date:  2013-06-03       Impact factor: 0.660

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.